1986

AIDS. [slide]
Garden Grove, CA : Medcom, 1986- slides : col. with b&w + sound cassettes ( min. : 1 7/8 ips) + guides (FTMM) Unique Identifier : AIDSLINE AV/8600444A
Greenwood JR
[SIDA : realites et fantasmes.]
Paris : P.O.L., c1984 168 p Unique Identifier : AIDSLINE CAT/8605240
Rozenbaum W
Clinical aspects of AIDS and AIDS-related complex.
Oxford ; New York : Oxford University Press, 1986 xx, 209 p. : ill (Oxford medical publications) Unique Identifier : AIDSLINE CAT/8604580
Staquet MJ; Hemmer R; Baert AE
AIDS, from the beginning.
Chicago : American Medical Association, c1986 xxxviii, 441 p. : ill., ports Unique Identifier : AIDSLINE CAT/8605309
Cole HM; Lundberg GD
The:Social dimensions of AIDS : method and theory.
New York : Praeger, 1986 viii, 274 p. : ill Unique Identifier : AIDSLINE CAT/8604808
Feldman DA; Johnson TM
Acquired immune deficiency syndrome : manual for professional health care providers.
San Diego, CA : Cabashon Pub., c1986 xii, 58 p Unique Identifier : AIDSLINE CAT/8604541
John E; Kruzic P; Griffin E
Mobilizing against AIDS : the unfinished story of a virus.
Cambridge, Mass. : Harvard University Press, 1986 x, 212 p. : ill Unique Identifier : AIDSLINE CAT/8605125
Nichols EK
Animal models of retrovirus infection and their relationship to AIDS.
Orlando : Academic Press, 1986 xix, 470 p. : ill Unique Identifier : AIDSLINE CAT/8604548
Salzman LA
INTERFERON ALPHA-2: CLINICAL TRIALS IN NON-HEMATOLOGIC MALIGNANCIES
Dev Oncol; 27:93-7 1985. Unique Identifier : AIDSLINE ICDB/86620275
Spiegel RJ; Schering Corporation, Kenilworth, NJ 07033
Phase II studies using alpha-2 interferon (INTRON) for treatment of nonhematologic malignancies are discussed. Results with INTRON as well as with other interferon products have generally been negative in most adult solid tumors (eg, breast, colon, and lung); most studies were conducted in patients with advanced disea


HODGKIN'S DISEASE AND THE NON-HODGKIN'S LYMPHOMAS
Cancer - Principles and Practice of Oncology. 2nd Edition. DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia, Lippincott, p. 1623-709, 1985.. Unique Identifier : AIDSLINE ICDB/86620340
DeVita VT Jr; Jaffe ES; Hellman S; NCI, Bethesda, MD
Hodgkin s disease and the non-Hodgkin s lymphomas are reviewed under the following headings: etiology and epidemiology, microscopic anatomy of normal lymphoid tissues (lymphoreticular cell surface markers; identification of lymphoreticular cells with monoclonal antibodies), cellular origin of the lymphomas (pathology


INFECTIONS IN THE CANCER PATIENT
Cancer - Principles and Practice of Oncology. 2nd Edition. DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia, Lippincott, p. 1963-98, 1985.. Unique Identifier : AIDSLINE ICDB/86620354
Pizzo PA; Young RC; Infectious Disease Section, Pediatric Branch, NCI, Bethesda, MD
Infections in the cancer patient (pt) are discussed with respect to impaired host defense (integumentary and mucosal barriers; phagocytic defenses; cellular and humoral immunity; reticulodendothelial system and splenectomy; nutrition; exogenous and endogenous microbial flora; acquired immunodeficieny syndrome), initia


CANCER IN THE IMMUNOSUPPRESSED HOST
Cancer - Principles and Practice of Oncology. 2nd Edition. DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia, Lippincott, p. 1999-2006, 1985.. Unique Identifier : AIDSLINE ICDB/86620355
Blattner WA; Hoover RN; Family Studies Section, Environmental Epidemiology Branch, Div.; of Cancer Etiology, NCI, Bethesda, MD
Congenital immune deficiency, drug-induced immunodeficiency, clinical conditions associated with altered immunity, and acquired immunodeficiency syndrome (AIDS) are each reviewed with respect to development of malignancies. Fourteen naturally occurring, genetically determined immunodeficiency diseases have been define


AIDS in the work place: the ethical ramifications.
Bus Health. 1986 Jan-Feb;3(3):30-4. Unique Identifier : AIDSLINE AHA/86132152
Bayer R; Oppenheimer G
Impact of A.I.D.S. on laboratory medicine.
Can J Med Technol. 1985 Dec;47(4):266. Unique Identifier : AIDSLINE AHA/86132979
Rennie RP
AIDS and health care in the laboratory.
Can J Med Technol. 1985 Dec;47(4):267-8. Unique Identifier : AIDSLINE AHA/86132980
Gilmore N
AIDS: a primary concern for the pathologist.
Can J Med Technol. 1985 Dec;47(4):269-70. Unique Identifier : AIDSLINE AHA/86132981
Jothy S; Bernier S
AIDS patients' confidentiality is medical records challenge.
Mod Healthc. 1985 Nov 22;15(24):86. Unique Identifier : AIDSLINE AHA/86146480
Siegner CA
AIDS poses significant legal considerations for the work place.
Bus Health. 1986 Jan-Feb;3(3):50-1. Unique Identifier : AIDSLINE AHA/86132158
Stromberg CD
AIDS and the substance abuse treatment clinician [editorial]
J Subst Abuse Treat. 1985;2(3):137. Unique Identifier : AIDSLINE MED/86143936
Imhof J; Hirsch R; Terenzi R
[AIDS--facts and fiction]
Med Pregl. 1985;38(9-10):429-33. Unique Identifier : AIDSLINE MED/86146366
Karlovac M
Reactive hemophagocytic syndrome.
Pediatr Pathol. 1985;3(2-4):129-41. Unique Identifier : AIDSLINE MED/86148914
Arya S; Hong R; Gilbert EF
Two cases of reactive hemophagocytic syndrome (RHS) are reported, and the clinical and pathological features are compared with other histiocytic proliferative disorders, including familial hemophagocytic lymphohistiocytosis (FHL) and malignant histiocytosis. RHS can be associated with a variety of infections, includin


[Current topics in tuberculosis]
Prax Klin Pneumol. 1985 Dec;39 Suppl 1:739-79. Unique Identifier : AIDSLINE MED/86149102
AIDS-induced decline of the incidence of syphilis in Denmark.
Acta Derm Venereol (Stockh). 1985;65(6):567-9. Unique Identifier : AIDSLINE MED/86154693
Poulsen A; Ullman S
The incidence rate of acquired syphilis per 100 000 total population in Denmark increased by 70% from 6.8 in 1978 to 11.6 in 1982. In 1984 this incidence had decreased by 61.2% to 4.5. The fluctuation of the number of acquired syphi


[Gastrointestinal manifestations of AIDS]
Ann Gastroenterol Hepatol (Paris). 1985 Dec;21(6):389-91. Unique Identifier : AIDSLINE MED/86157418
Rene E; Chevalier T; Godeberge B; Bonfils S
We studied 26 cases of digestive manifestation in AIDS. The 26 patients were divided into two different epidemiological groups: 13 homosexual men, constituted the first group; no homosexual patient was in the second group which included 6 haitians, 6 africans and a pakistanian. The clinical manifestation were: a water


[We dentists and AIDS]
Inf Dent. 1985 Oct 3;67(34):3511-4. Unique Identifier : AIDSLINE MED/86138576
Zeitoun R
[Good clinic hygiene is important]
Tandteknikern. 1985 Aug;54(7-8):268, 270-1. Unique Identifier : AIDSLINE MED/86152439
Johansson T
[AIDS virus infection: increase risk of infection for dentists]
Zahnarztl Mitt. 1985 Oct 1;75(19):2102, 2104-6, 2108 passim. Unique Identifier : AIDSLINE MED/86154402
Reichart PA; Gelderblom HR; Koch MA
[Anti-ATLA (antibodies to adult T-cell leukemia-associated antigen) in the East coast of Kii Peninsula]
Rinsho Ketsueki. 1985 Oct;26(10):1608-13. Unique Identifier : AIDSLINE MED/86144377
Ucida T; Kobayashi T; Matsuoka N; Shimizu N; Furuta I; Katayama N; Koh T; Kita K; Tanaka I; Minami N; et al
[Recent advances in histiocytosis]
Pediatr Med Chir. 1985 Mar-Apr;7(2):181-8. Unique Identifier : AIDSLINE MED/86148695
Nespoli L; Arico M; Burgio VL
Histiocytosis is the term currently used to describe the group of diseases characterized by activation and proliferation of monocytic-mononuclear cells. Some of these are reactive to well-known causes, mycobacteriae, viral and parasitic infections, or chronic storage of minerals. Wider and more intriguing is the group


[Bronchoalveolar lavage]
Prax Klin Pneumol. 1985 Dec;39 Suppl 1:920-33. Unique Identifier : AIDSLINE MED/86149109
[Acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire: clinical and epidemiological observations]
Ann Soc Belg Med Trop. 1985;65(4):357-61. Unique Identifier : AIDSLINE MED/86157841
Odio W; Kapita B; Mbendi N; Kayembe K; Ndangi K; Muyembe T; Mazebo P; Izzia K; Lurhuma Z; Sansa A; et al
[Advances in research on AIDS]
Chung Hua Nei Ko Tsa Chih. 1985 Oct;24(10):627-9. Unique Identifier : AIDSLINE MED/86135048
Gu CH
[Acquired immune deficiency syndrome--AIDS]
Vojnosanit Pregl. 1985 Sep-Oct;42(5):372-9. Unique Identifier : AIDSLINE MED/86153663
Bojic I
Shigella flexneri bacteraemia in a patient with acquired immune deficiency syndrome.
Acta Clin Belg. 1985;40(6):388-90. Unique Identifier : AIDSLINE MED/86154664
Glupczynski Y; Hansen W; Jonas C; Deltenre M
Cell replication in an immunologically(?) Stimulated cell population in human bone marrow.
Ann N Y Acad Sci. 1985;459:67-72. Unique Identifier : AIDSLINE MED/86157298
Greenberg ML; Siegal FP
In AIDS, although there is a lack of humoral responsiveness in vitro and in vivo, many patients persistently have an increased number of B cells which continue to produce increased amounts of immunoglobulin. An objective, reproducible morphologic classification scheme for B cells was devised. Comparison of cell kineti


Health care workers with AIDS [letter]
Can Med Assoc J. 1986 Mar 15;134(6):573. Unique Identifier : AIDSLINE MED/86133018
Cord MS
AIDS hysteria [letter]
Can Med Assoc J. 1986 Mar 15;134(6):573, 575. Unique Identifier : AIDSLINE MED/86133019
Katz JC
Excessive concern about AIDS in two bisexual men.
Can J Psychiatry. 1986 Feb;31(1):63-5. Unique Identifier : AIDSLINE MED/86133085
Lippert GP
The Acquired Immune Deficiency Syndrome (AIDS) has become an increasingly common cause of severe morbidity and death among homosexual men. As such it has become a major source of concern to this group. In this paper I report the cases of two bisexual men who developed a severe illness characterized by fatigue, malaise


The coronary circulation in human septic shock.
Circulation. 1986 Apr;73(4):637-44. Unique Identifier : AIDSLINE MED/86134070
Cunnion RE; Schaer GL; Parker MM; Natanson C; Parrillo JE
Reversible myocardial depression, manifested by ventricular dilatation and decreased ejection fraction, is common in human septic shock. A proposed mechanism, based on animal studies, is myocardial ischemia resulting from inadequate coronary blood flow. Coronary flow observations have not been reported for human septi


Monoclonal immunoglobulins in HTLV III-positive sera [letter]
Clin Chem. 1986 Mar;32(3):574. Unique Identifier : AIDSLINE MED/86134217
Sala PG; Mazzolini S; Tonutti E; Bramezza M
Neuropathologic findings in the acquired immunodeficiency syndrome (AIDS).
Clin Neuropathol. 1986 Jan-Feb;5(1):1-20. Unique Identifier : AIDSLINE MED/86134315
Anders K; Steinsapir KD; Iverson DJ; Glasgow BJ; Layfield LJ; Brown WJ; Cancilla PA; Verity MA; Vinters HV
The acquired immunodeficiency syndrome (AIDS) is characterized by a severe idiopathic deficiency in T-cell mediated immunity. Homosexuals, intravenous drug abusers and Haitians are predominantly affected, predisposing them to opportunistic infections and neoplasms. In this study, the central nervous system (CNS) was e


AIDS and the physician's fear of contagion.
Chest. 1986 Mar;89(3):325-6. Unique Identifier : AIDSLINE MED/86134876
Loewy EH
[Proliferation of accessory cells in LAS and AIDS (letter)]
Dtsch Med Wochenschr. 1986 Feb 14;111(7):278. Unique Identifier : AIDSLINE MED/86135518
Muller H; Falk S; Stutte HJ
Detection of the X gene product of simian T-cell leukemia virus.
FEBS Lett. 1986 Feb 17;196(2):301-4. Unique Identifier : AIDSLINE MED/86136537
Tsujimoto A; Tsujimoto H; Yanaihara N; Abe K; Hayami M; Miwa M; Shimotohno K
The gene product of the X region was examined in simian lymphoid cell lines producing simian T-cell leukemia virus (STLV), which is closely related to human T-cell leukemia virus (HTLV). By use of specific antibodies against pX peptides of HTLV-I, a protein of 41 kDa was identified as a pX product of STLV.


Transfusion-related acquired immunodeficiency syndrome and directed donations: would the national blood supply be safer with directed donations?
Hum Pathol. 1986 Feb;17(2):108-10. Unique Identifier : AIDSLINE MED/86138270
Umlas J
Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons.
J Infect Dis. 1986 Mar;153(3):570-8. Unique Identifier : AIDSLINE MED/86141988
Ungar BL; Soave R; Fayer R; Nash TE
Cryptosporidium is a parasite of the human gastrointestinal tract and has a worldwide distribution. We developed a sensitive and reproducible enzyme immunoassay for detection of serum IgG or IgM to Cryptosporidium. For IgG, 13 of 15 patients with cryptosporidiosis and 26 of 26 patients with cryptosporidiosis and AIDS


When should the sick doctor stop caring for patients, and who will make that decision?
J Fla Med Assoc. 1986 Jan;73(1):43-5. Unique Identifier : AIDSLINE MED/86142578
Feinstein RJ
Japan screens donated blood [news]
Nature. 1986 Feb 20-26;319(6055):610. Unique Identifier : AIDSLINE MED/86146826
Swinbanks D
Immunosuppressants in patients with AIDS [letter]
Nature. 1986 Mar 13-19;320(6058):114. Unique Identifier : AIDSLINE MED/86146890
Hausen A; Dierich MP; Fuchs D; Hengster P; Reibnegger G; Schulz T; Werner ER; Wachter H
Did mycotoxins play a role in bubonic plague epidemics?
Perspect Biol Med. 1986 Winter;29(2):244-56. Unique Identifier : AIDSLINE MED/86148380
Matossian MK
Acquired immunodeficiency syndrome in a thalassemic child.
Pediatr Infect Dis. 1986 Mar-Apr;5(2):274-6. Unique Identifier : AIDSLINE MED/86148747
Paul R; Dobkin D; Maurer H; Noah Z; Yogev R
Hepatitis in clinical practice. 1. Hepatitis A and B.
Postgrad Med. 1986 Mar;79(4):194-200, 209-14. Unique Identifier : AIDSLINE MED/86148981
Sarver DK
As is evident from the foregoing discussion, hepatitis A and hepatitis B are not static, passe disease. Knowledge concerning these illnesses continues to expand at a fantastic rate--all of it of extreme practical clinical significance. Most interesting is the elucidation of the etiology of the acquired immune deficien


Disabling fear of AIDS responsive to imipramine.
Psychosomatics. 1986 Feb;27(2):143-4. Unique Identifier : AIDSLINE MED/86150082
Jenike MA; Pato C
AIDS: definition and guidelines for the health professional.
Radiol Technol. 1986 Jan-Feb;57(3):233-5. Unique Identifier : AIDSLINE MED/86150291
Healey MJ Jr
AIDS is a lethal infectious disease that must certainly be dealt with carefully, but through conscientious application of well-established procedures and techniques, health care professionals may provide the best possible care to the patients suffering the ravages of this disease without undue risk to themselves or th


AIDS-related lymphomas: evaluation by abdominal CT.
Radiology. 1986 Apr;159(1):59-63. Unique Identifier : AIDSLINE MED/86150358
Nyberg DA; Jeffrey RB Jr; Federle MP; Bottles K; Abrams DI
Recent evidence indicates that individuals with acquired immunodeficiency syndrome (AIDS) or those at high risk for AIDS have an increased occurrence of lymphoma. AIDS-related lymphomas (ARLs) often present with an advanced stage of disease and highly malignant histologic subtypes. This study reviewed the abdominal co


Congress likely to halt shrinkage in AIDS funds [news]
Science. 1986 Mar 21;231(4744):1364-5. Unique Identifier : AIDSLINE MED/86151646
Norman C
Structural analysis of p19 and p24 core polypeptides of primate lymphotropic retroviruses (PLRV).
Virology. 1986 Apr 15;150(1):291-8. Unique Identifier : AIDSLINE MED/86153619
Jurkiewicz E; Nakamura H; Schneider J; Yamamoto N; Hayami M; Hunsmann G
Core polypeptides of primate lymphotropic retroviruses (PLRV) have very similar molecular weights. To discriminate between individual PLRVs we have compared two-dimensional tryptic peptide maps of 125I-labeled core polypeptides p19 and p24 of 11 isolates originating from humans and six simian species. Peptide maps sho


AIDS transmission [letter]
West J Med. 1986 Jan;144(1):92. Unique Identifier : AIDSLINE MED/86153892
Campbell JM
The thymus in AIDS [letter]
Am J Clin Pathol. 1986 Apr;85(4):531. Unique Identifier : AIDSLINE MED/86155637
Welch K
The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin.
Am J Pathol. 1986 Mar;122(3):493-9. Unique Identifier : AIDSLINE MED/86156112
Rutgers JL; Wieczorek R; Bonetti F; Kaplan KL; Posnett DN; Friedman-Kien AE; Knowles DM 2d
The authors investigated 19 cases of Kaposi s sarcoma (KS) obtained from patients with the acquired immune deficiency syndrome (AIDS) for their expression of Factor VIII-related antigen (FVIIIRAg), HLA-DR (Ia) antigens, OKM1, and three distinctive vascular, but not lymphatic, endothelial-cell-associated antigens, E92,


Psychological themes in patients with acquired immune deficiency syndrome [letter]
Am J Psychiatry. 1986 Apr;143(4):551. Unique Identifier : AIDSLINE MED/86156382
Hays LR; Lyles MR
Immune thrombocytopenia in homosexual men [letter]
Ann Intern Med. 1986 Apr;104(4):583-4. Unique Identifier : AIDSLINE MED/86157232
Haemophilia, blood transfusion, and the AIDS virus [editorial]
Arch Dis Child. 1986 Feb;61(2):105-7. Unique Identifier : AIDSLINE MED/86157723
Lilleyman JS
Indications for and diagnostic efficacy of open-lung biopsy in the patient with acquired immunodeficiency syndrome (AIDS).
Ann Thorac Surg. 1986 Mar;41(3):307-12. Unique Identifier : AIDSLINE MED/86157900
Pass HI; Potter D; Shelhammer J; Macher A; Ognibene FP; Longo DL; Gelmann E; Masur H; Roth JA
Pulmonary infiltrates in the patient with acquired immunodeficiency syndrome (AIDS) may be associated with a spectrum of unusual neoplastic and infectious process. Transbronchial biopsy frequently reveals the cause of these infiltrates; however, when transbronchial biopsy is nondiagnostic or contraindicated, or if the


Diffuse toxoplasmic retinochoroiditis in a patient with AIDS.
Arch Ophthalmol. 1986 Apr;104(4):571-5. Unique Identifier : AIDSLINE MED/86158483
Parke DW 2d; Font RL
Ocular toxoplasmosis typically presents as a focal necrotizing retinochoroiditis. We report a case of diffuse necrotizing retinochoroiditis due to toxoplasmosis in a patient with the acquired immunodeficiency syndrome (AIDS). The appearance at initial presentation was similar to the acute retinal necrosis syndrome. We


The nondiagnosis of acquired immunodeficiency syndrome [editorial]
Arch Pathol Lab Med. 1986 Apr;110(4):307-8. Unique Identifier : AIDSLINE MED/86158157
Hensley GT; Moskowitz L
Disseminated Kaposi's sarcoma that is not associated with acquired immunodeficiency syndrome in a bisexual man.
Arch Pathol Lab Med. 1986 Apr;110(4):346-7. Unique Identifier : AIDSLINE MED/86158166
Marquart KH; Oehlschlaegel G; Engst R
We report a case of a moderately disseminated, slowly progressing Kaposi s sarcoma, with a primary cutaneous nodule on the glans penis. The multifocal skin tumor appeared in a 44-year-old bisexual man and was not associated with acquired immunodeficiency syndrome.


Drug abusers 'most likely' to spread AIDS virus by needles.
Nurs Stand. 1986 Feb 6;(433):8. Unique Identifier : AIDSLINE MED/86147085
Casey N
The AIDS hysteria: how it began and what nurses can do [editorial]
AORN J. 1986 Feb;43(2):418, 420. Unique Identifier : AIDSLINE MED/86157493
Palmer PN
The acquired immunodeficiency syndrome: current perspectives and future directions.
Drug Intell Clin Pharm. 1986 Feb;20(2):153-4. Unique Identifier : AIDSLINE MED/86135463
Minor JR
The transmission and manifestations of acquired immunodeficiency syndrome (AIDS).
Dent Hyg (Chic). 1986 Jan;60(1):10-4. Unique Identifier : AIDSLINE MED/86136811
Brown BS
Patients' concerns about AIDS [letter]
J Am Dent Assoc. 1986 Feb;112(2):162, 164. Unique Identifier : AIDSLINE MED/86141263
Roberson B; Smith T
The acquired immunodeficiency syndrome. Infection control and public health law.
N Engl J Med. 1986 Apr 3;314(14):931-6. Unique Identifier : AIDSLINE MED/86146824
Mills M; Wofsy CB; Mills J
New scarlet letter(s), pediatric AIDS.
Pediatrics. 1986 Mar;77(3):423-7. Unique Identifier : AIDSLINE MED/86148282
Church JA; Allen JR; Stiehm ER
American Academy of Pediatrics. Committee on School Health, Committee on Infectious Diseases. School attendance of children and adolescents with human T lymphotropic virus III/lymphadenopathy-associated virus infection.
Pediatrics. 1986 Mar;77(3):430-2. Unique Identifier : AIDSLINE MED/86148284
Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS.
Blood. 1986 Mar;67(3):831-4. Unique Identifier : AIDSLINE MED/86132010
Archibald DW; Zon L; Groopman JE; McLane MF; Essex M
Whole saliva samples collected from available people at risk in Boston for infection with human T-lymphotropic virus type III (HTLV-III/LAV), from late 1984 through early 1985, were analyzed for the presence of antibodies to viral proteins. Fourteen of 20 (70%) acquired immunodeficiency syndrome (AIDS) patients and 14


Abnormal monocyte function in patients with Kaposi's sarcoma.
Cancer. 1986 Apr 15;57(8):1501-6. Unique Identifier : AIDSLINE MED/86133132
Braun DP; Harris JE
Monocyte-mediated functions were evaluated in the peripheral blood mononuclear cells (PBMC) of 11 previously untreated patients with Kaposi s sarcoma in association with the acquired immune deficiency syndrome (KS/AIDS). All patients had lymphadenopathy, an abnormal OKT.4/OKT.8 ratio, and a good performance status; no


Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome.
Clin Pharmacol Ther. 1986 Mar;39(3):271-5. Unique Identifier : AIDSLINE MED/86134389
Stahl-Bayliss CM; Kalman CM; Laskin OL
We conducted an analysis of 37 patients with the acquired immune deficiency syndrome (AIDS) who received pentamidine for the treatment of Pneumocystis carinii pneumonia to quantitate the incidence and severity of pentamidine-induced hypoglycemia. Ten of these patients (27%), nine of whom were symptomatic, developed hy


Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males.
J Am Dent Assoc. 1986 Feb;112(2):187-92. Unique Identifier : AIDSLINE MED/86141271
Silverman S Jr; Migliorati CA; Lozada-Nur F; Greenspan D; Conant MA
A total of 375 homosexual males were studied to assess the dental findings, life-style, and risk factors during a 4-year period. At baseline, 136 of the patients were diagnosed as having AIDS, 116 were considered at risk for AIDS, and 123 were considered healthy. In a mean follow-up time of 23 months, nine of the pati


How killer cells kill their targets [news]
Science. 1986 Mar 21;231(4744):1367-9. Unique Identifier : AIDSLINE MED/86151648
Marx JL
Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome.
Ann Intern Med. 1986 Apr;104(4):511-4. Unique Identifier : AIDSLINE MED/86157217
Whimbey E; Gold JW; Polsky B; Dryjanski J; Hawkins C; Blevins A; Brannon P; Kiehn TE; Brown AE; Armstrong D
Forty-nine episodes of bacteremia and fungemia occurred in 38 of 336 patients with the acquired immunodeficiency syndrome seen at our institution since 1980. There were five types of infections. Infections commonly associated with a T-cell immunodeficiency disorder comprised 16 episodes and included those with Salmone


Kaposi's sarcoma: a comprehensive review.
J Foot Surg. 1986 Jan-Feb;25(1):78-81. Unique Identifier : AIDSLINE MED/86141468
Aquino L; Aquino MD; Aquino JM
Kaposi s sarcoma is a neoplasm that is usually malignant and occurs in the skin and sometimes in the lymph nodes and internal organs. The cause is unknown, but recently it has become epidemic because of its involvement in acquired immune deficiency syndrome (AIDS). Although it is worldwide in distribution, the disease


Serotypes of Cryptococcus neoformans in patients with AIDS [letter]
J Infect Dis. 1986 Mar;153(3):642. Unique Identifier : AIDSLINE MED/86142004
Rinaldi MG; Drutz DJ; Howell A; Sande MA; Wofsy CB; Hadley WK
False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis [letter]
N Engl J Med. 1986 Apr 3;314(14):921-2. Unique Identifier : AIDSLINE MED/86146815
Mendenhall CL; Roselle GA; Grossman CJ; Rouster SD; Weesner RE
[Lung complications in AIDS]
Radiologe. 1986 Jan;26(1):3-9. Unique Identifier : AIDSLINE MED/86150299
Weiske R; Buck J; Schneider R; Hannemann T; Krauss B
A short description of epidemiologic and clinical facts correlated with the acquired immunodeficiency syndrome (AIDS) is followed by a report on the manifestation of pulmonary infections mostly effected by Pneumocystis carinii. Two examples out of four cases will demonstrate the radiographic appearance of the Pneumocy


Nucleotide sequence of the protease-coding region in an infectious DNA of simian retrovirus (STLV) of the HTLV-I family.
Virology. 1986 Apr 15;150(1):187-95. Unique Identifier : AIDSLINE GENBANK/J02029
Inoue J; Watanabe T; Sato M; Oda A; Toyoshima K; Yoshida M; Seiki M
A provirus clone of simian T-cell leukemia virus isolated from a pigtailed monkey (PT-STLV), which is 90% homologous to HTLV-I, was shown to be biologically active in transfection assay. In transfected cells, gp61env, Pr55gag, and the mature gag proteins p24, p21, and p15 were detected, and type C particles were produ


AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations.
Blood. 1986 Mar;67(3):592-5. Unique Identifier : AIDSLINE MED/86131971
Ragni MV; Tegtmeier GE; Levy JA; Kaminsky LS; Lewis JH; Spero JA; Bontempo FA; Handwerk-Leber C; Bayer WL; Zimmerman DH; et al
Antibodies to the AIDS retrovirus, specifically to human T cell lymphotropic virus, type III, and AIDS-associated retrovirus, were detected with increasing prevalence in a population of 190 hemophiliacs from western Pennsylvania between 1981 and 1984: 7.7% in 1981, 20.0% in 1982, 45.5% in 1983, and 62.5% in 1984. The


Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.
Blood. 1986 Mar;67(3):666-71. Unique Identifier : AIDSLINE MED/86131982
Taylor J; Afrasiabi R; Fahey JL; Korns E; Weaver M; Mitsuysau R
Sixteen immunological parameters were assessed quantitatively for their value in providing an immunologically-based and prognostically significant classification of the immune alteration in 97 patients with AIDS and Kaposi s sarcoma (AIDS-KS). The dimensions of reductions in the T4 (T helper-inducer cells) subpopulati


AIDS associated Kaposi's sarcoma in Africa [letter]
Br Med J (Clin Res Ed). 1986 Feb 15;292(6518):484. Unique Identifier : AIDSLINE MED/86132477
Marquart KH
Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.
Br Med J (Clin Res Ed). 1986 Feb 22;292(6519):527-9. Unique Identifier : AIDSLINE MED/86132501
Robertson JR; Bucknall AB; Welsby PD; Roberts JJ; Inglis JM; Peutherer JF; Brettle RP
Stored blood samples from 164 intravenous drug abusers who attended a Scottish general practice were tested for HTLV-III/LAV (human T cell lymphotropic virus type III/lymphadenopathy associated virus) infection. Of those tested, 83 (51%) were seropositive, which is well above the prevalence reported elsewhere in Brita


Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy.
Cancer. 1986 Apr 15;57(8 Suppl):1657-61. Unique Identifier : AIDSLINE MED/86133156
Mitsuyasu RT; Taylor JM; Glaspy J; Fahey JL
Kaposi s sarcoma (KS) in acquired immune deficiency syndrome (AIDS) is a new manifestation of a previously rare disease, and generally has a fatal course. Variations in the clinical course and in response to treatment by patients with this disease suggest that specific immunologic or clinical parameters may be importa


Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors.
Cancer. 1986 Apr 15;57(8 Suppl):1662-5. Unique Identifier : AIDSLINE MED/86133157
Krown SE; Real FX; Vadhan-Raj S; Cunningham-Rundles S; Krim M; Wong G; Oettgen HF
Interferon alfa-2a (Roferon-A, Hoffmann-La Roche Inc., Nutley, NJ) was used to treat sequential groups of patients with Kaposi s sarcoma associated with the acquired immune deficiency syndrome (AIDS). Major antitumor effects (complete or partial responses) were observed in 38% o


[Listeria sepsis in AIDS (letter)]
Dtsch Med Wochenschr. 1986 Feb 21;111(8):316-7. Unique Identifier : AIDSLINE MED/86135528
Thiel M; Kindt R; Schmidt H; Schassan H; Potel J
Hematologic care of the surgical patient.
Hosp Pract (Off Ed). 1986 Feb 15;21(2):124DD, 124GG-124HH, 124JJ passim. Unique Identifier : AIDSLINE MED/86140483
Berkman SA
AIDS virus infection: prognosis and transmission [letter]
J R Soc Med. 1986 Feb;79(2):121-3. Unique Identifier : AIDSLINE MED/86143608
Serotherapy for AIDS and pre-AIDS syndrome [letter]
Nature. 1986 Mar 13-19;320(6058):113-4. Unique Identifier : AIDSLINE MED/86146888
Sewell HF; Walker F
Hepatitis B vaccine cannot transmit AIDS. Health officials stress need to continue inoculations.
ADA News. 1985 Jan 7;16(1):1, 3. Unique Identifier : AIDSLINE MED/86131041
In situ quantitation of lymph node helper, suppressor, and cytotoxic T cell subsets in AIDS.
Blood. 1986 Mar;67(3):596-603. Unique Identifier : AIDSLINE MED/86131972
Wood GS; Burns BF; Dorfman RF; Warnke RA
We have used the novel monoclonal antibodies 9.3 and anti-Leu-8 in conjunction with other T cell markers to quantify T cell subpopulations in the paracortex, mantle, and germinal center compartments of frozen sections of lymph nodes from seven homosexual men with acquired immunodeficiency syndrome (AIDS) and five hete


Hepatitis B vaccine and AIDS [letter]
J Can Dent Assoc. 1986 Feb;52(2):115. Unique Identifier : AIDSLINE MED/86132964
Epstein JB
AIDS. Chicago dentists battle a new disease in the operatory.
CDS Rev. 1986 Jan-Feb;79(1):37-9. Unique Identifier : AIDSLINE MED/86133574
Hoekstra LJ
[Causes of death in hemophilia patients in East Germany]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1985;112(6):845-52. Unique Identifier : AIDSLINE MED/86137849
Schiller WG; Hartmann G; Remde W
By means of the Central Card Index of Haemophilia, a working material of the Section of Haemophilia in the Society of Haematology and Blood Transfusion of the GDR, 52 patients with heriditary haemorrhagic diatheses could be registered. These persons had died between 1962 and 1984. The average age of death amounted to


Seborrheic dermatitis and acquired immunodeficiency syndrome [letter]
J Am Acad Dermatol. 1986 Jan;14(1):147-8. Unique Identifier : AIDSLINE MED/86141012
Skinner RB Jr; Zanolli MD; Noah PW; Rosenberg EW
Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study.
J Am Acad Dermatol. 1986 Feb;14(2 Pt 1):242-8. Unique Identifier : AIDSLINE MED/86141036
Soeprono FF; Schinella RA; Cockerell CJ; Comite SL
We studied twenty-five skin biopsies from twenty-one patients with acquired immunodeficiency syndrome or its prodrome who presented with the seborrheic dermatitis associated with acquired immunodeficiency syndrome and compared them with an equal number of biopsies from patients with seborrheic dermatitis who had neith


Acquired immunodeficiency syndrome: impact and implication for the neurological system.
J Neurosci Nurs. 1986 Feb;18(1):5-10. Unique Identifier : AIDSLINE MED/86142149
Beckham MM; Rudy EB
Acquired immunodeficiency syndrome (AIDS) has reached epidemic proportions throughout the world. Because at least 40% of AIDS victims are neurologically symptomatic, the neuroscience nurse must be prepared to care for increasing numbers of these patients. This article will define the syndrome, identify risk groups, an


Childhood acquired immune deficiency syndrome manifesting as acrodermatitis enteropathica.
J Pediatr. 1986 Mar;108(3):426-8. Unique Identifier : AIDSLINE MED/86143213
Tong TK; Andrew LR; Albert A; Mickell JJ
Persistent generalized lymphadenopathy: immunological and mycological investigations.
Acta Derm Venereol (Stockh). 1985;65(6):515-20. Unique Identifier : AIDSLINE MED/86154677
Torssander J; Wasserman J; Morfeldt-Mansson L; Petrini B; von Stedingk LV
Immunological and mycological investigations were carried out in 21 Swedish homosexual males. One of them had AIDS, one pre-AIDS and 19 lymphadenopathy of whom 18 fulfilled the criteria of persistent generalized lymphadenopathy (PGL) as defined by the Centers for Disease Control, Atlanta, (CDC). The patients were inve


Dentists found at small risk to AIDS: LA task force. Virus may be killed easily; autoclaving, sterilization recommended.
ADA News. 1985 Sep 2;16(17):14-5, 19. Unique Identifier : AIDSLINE MED/86131045
Kaposi's sarcoma and HTLV-III infection. Virus-like particles in skin lesions: experimental observations.
Boll Ist Sieroter Milan. 1985;64(5):353-62. Unique Identifier : AIDSLINE MED/86131152
Cuneo Crovari P; Fusco FA; Ferrarini M; Nicolo G; Rosso R; Crovato F; Scarvaglieri R; Losi E; Mazzoleni C; Crovari P
Skin biopsies from a subject affected by KS and AIDS were examined by means of EM. Samples were obtained both in correspondence of a typical nodule, and from an apparently normal area. The disease process had started at least 8 mo. before, and the patient showed a reduced number of OKT4 cells, with an inversion of the


Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
Boll Ist Sieroter Milan. 1985;64(5):363-6. Unique Identifier : AIDSLINE MED/86131153
Anti-HTLV III had been detected in 12,689 serum samples collected within August 1985 from 12 Transfusion Centres of Liguria. In the course of the first test, carried out by ELISA using disrupted virions as antigen, 12,666 samples (99.81%) resulted non reactive; 14 (0.1%) belonged to the grey-zone and 9 (0.08%) were cl


Prevalence of infections caused by AIDS and hepatitis B viruses in jailed people.
Boll Ist Sieroter Milan. 1985;64(5):367-70. Unique Identifier : AIDSLINE MED/86131154
Crovari P; Cassini U; Infante D; Guano F; Icardi GC; Auteri G; Di Ponzio A; Cuneo Crovari P
Prevalence of positive subjects to anti-HTLV III and HBV markers (HBsAg; anti-HBc; anti-HBs) has been studied both among jailed people and wardens of Sanremo Jail. Out of 92 subjects in custody, 11 were anti-HTLV III positive and 44 had acquired HBV infection markers (antigen and/or antibodies). One of the wardens res


Immunohistochemical reactivity of anti-LAV p18 monoclonal antibody in lymph nodes from PGL and AIDS patients.
Boll Ist Sieroter Milan. 1985;64(5):422-4. Unique Identifier : AIDSLINE MED/86131165
Parravicini CL; Vago L; Costanzi GC; Gluckman JC; Klatzmann D; Berti E; Barre-Sinoussi F; Chermann JC; Lazzarin A; Moroni M
This study deals with the immunohistochemistry of a monoclonal antibody (Mab) raised against the p18 protein of the LAV virus in lymphnodes from 20 cases of persistent generalized lymphoadenopathy (PGL) (2) and 6 of acquired immunodeficiency syndrome (AIDS) (3). In all the PGL cases that have been studied, we observed


Pathogenesis of B cell lymphoma in a patient with AIDS.
Blood. 1986 Mar;67(3):612-5. Unique Identifier : AIDSLINE MED/86131974
Groopman JE; Sullivan JL; Mulder C; Ginsburg D; Orkin SH; O'Hara CJ; Falchuk K; Wong-Staal F; Gallo RC
Lymphoma occurs at increased frequency in patients with the acquired immunodeficiency syndrome (AIDS). We studied, using serologic and molecular techniques, one such lymphoma for (a) evidence of infection with human T lymphotropic virus, type III (HTLV-III), and Epstein-Barr virus (EBV), (b) monoclonal rearrangement o


Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma.
Blood. 1986 Mar;67(3):650-6. Unique Identifier : AIDSLINE MED/86131980
Smith SD; Morgan R; Link MP; McFall P; Hecht F
Cell lines were established from five patients with T cell malignancies. Two patients had T cell lymphoblastic lymphoma (T-LL), whereas three patients had T cell acute lymphoblastic leukemia (T-ALL). Both T-LL cell lines expressed cell surface antigens characteristic of midthymocytes (Leu 2, 3, 6+). One T-ALL cell lin


T-lymphotropic retroviruses of non-human primates.
Bull Pan Am Health Organ. 1985;19(4):399-400. Unique Identifier : AIDSLINE MED/86132144
The surgeon and HTLV-III infection [editorial]
Br J Surg. 1986 Mar;73(3):168-9. Unique Identifier : AIDSLINE MED/86132391
Forbes CD
AIDS and lymphadenopathy [editorial]
Br J Surg. 1986 Mar;73(3):170-1. Unique Identifier : AIDSLINE MED/86132392
Godley MJ
Clinical investigations of lymphadenopathy, including lymph node biopsies, in 24 homosexual men with antibodies to the human T-cell lymphotropic virus type III (HTLV-III).
Br J Surg. 1986 Mar;73(3):180-2. Unique Identifier : AIDSLINE MED/86132395
Farthing CF; Henry K; Shanson DC; Taube M; Lawrence AG; Harcourt-Webster JN; Gazzard B
The findings of 27 lymph node biopsies performed on 24 homosexual patients with lymphadenopathy are presented. Six had acquired immune deficiency syndrome (AIDS) and 18 lymphadenopathy only, of whom one subsequently developed AIDS. All these patients had antibodies to the human T-cell lymphotropic virus type III (HTLV


Surgical biopsy for persistent generalized lymphadenopathy.
Br J Surg. 1986 Mar;73(3):183-5. Unique Identifier : AIDSLINE MED/86132396
Rashleigh-Belcher HJ; Carne CA; Weller IV; Smith AM; Russell RC
Lymph node biopsy was performed in 39 homosexual men with unexplained persistent generalized lymphadenopathy (PGL). Thirty-seven (95 per cent) of these patients had antibodies to human T-lymphotropic virus type III (HTLV-III), at the time of biopsy. Histology in all but one showed only follicular hyperplasia, the exce


Strategy for lymph node biopsy in homosexual men suspected of having LAV/HTLV-III related disease.
Br J Surg. 1986 Mar;73(3):186-7. Unique Identifier : AIDSLINE MED/86132397
Scott HJ; Glynn MJ; Lane IF; Anderson MG; Theodorou NA; Murray-Lyon IM; Reynolds KW
Since January 1985 we have changed our policy regarding lymph node biopsy in male homosexuals presenting with lymphadenopathy. Before that date all such patients underwent biopsy if there was no apparent cause. We no longer perform biopsy in male homosexuals presenting with uncomplicated persistent generalized lymphad


Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.
Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):228-30. Unique Identifier : AIDSLINE MED/86132422
Lange JM; Coutinho RA; Krone WJ; Verdonck LF; Danner SA; van der Noordaa J; Goudsmit J
Longitudinal IgG recognition patterns of viral proteins were studied in 15 men who had seroconverted for lymphadenopathy associated virus/human T lymphotropic virus (LAV/HTLV-III). Antibodies to the major viral core protein p24, which is a cleavage product of the gag gene encoded precursor protein pr55, appeared first


AIDS and taurolin [letter]
Can Med Assoc J. 1986 Mar 1;134(5):476. Unique Identifier : AIDSLINE MED/86133008
Bayardelle P
Human T-lymphotropic virus: exposure and prognosis [letter]
Can Med Assoc J. 1986 Mar 15;134(6):575-7. Unique Identifier : AIDSLINE MED/86133020
Soskolne CL; Heyland D; Phillips E
Hepatitis B virus (HBV) DNA in leucocytes in acquired immune deficiency syndrome (AIDS).
Cytobios. 1985;44(176):119-28. Unique Identifier : AIDSLINE MED/86134807
Lie-Injo LE; Volberding P; Golden JA; Herrera AR
Earlier reported findings of hepatitis B virus (HBV) DNA in white blood cells of patients with hepatoma, and in a patient with autoimmune haemolytic anaemia, led to the examination of HBV DNA in a series of twenty three patients with acquired immune deficiency syndrome (AIDS), including nine with opportunistic infecti


[HTLV-III in persons with intravenous drug abuse. Correlation of antibodies against HTLV-III with neopterin and TH/TS]
Dtsch Med Wochenschr. 1986 Mar 21;111(12):453-7. Unique Identifier : AIDSLINE MED/86135497
Hengster P; Blecha HG; Deinhardt F; Erfle V; Fuchs D; Goebel FD; Gurtler LG; Hausen A; Hinterhuber H; Reibnegger G; et al
Antibodies against HTLV-III, neopterin levels in blood and urine, TH/TS ratio and hepatitis marker were determined in 34 clinically symptom-free persons known to be intravenous drug abusers. 15 persons were positive in the ELISA and Western-blot tests. There was a strong reaction to protein p24 compared with that to p


[HTLV-III/LAV and resuscitation]
Dtsch Med Wochenschr. 1986 Mar 21;111(12):476-7. Unique Identifier : AIDSLINE MED/86135502
Kroegel C; Hess G; Meyer zum Buschenfelde KH
Detection of anti-HTLV-III/LAV antibody by enzyme-linked immunosorbent assay in high-risk individuals in Switzerland 1974-1985.
Eur J Clin Microbiol. 1985 Dec;4(6):583-6. Unique Identifier : AIDSLINE MED/86136068
Stroun J; Graf I; Frei PC
Anti-HTLV-III antibody was tested in frozen sera from high-risk individuals, collected between 1974 and 1985 in Switzerland . All but one of the 262 sera of a control group were negative. Among drug addicts, none of the 78 samples collected from 1974 to 1979 was positive. Antib


Biochemical heterogeneity of reverse transcriptase purified from the AIDS virus, HTLV-III.
FEBS Lett. 1986 Mar 3;197(1-2):84-8. Unique Identifier : AIDSLINE MED/86136607
Chandra A; Gerber T; Chandra P
The reverse transcriptase from AIDS virus, HTLV-III, was purified and characterized. The purified enzyme has a very high affinity for template primers (rC)n X (dG)12 and (rCm)n X (dG)12 compared to that for (rA)n X (dT)12. In addition, the HTLV-III reverse transcriptase was able to transcribe (rAm)n X (dT)12 very effi


Acquired immune deficiency syndrome and the fertility clinic.
Fertil Steril. 1986 Feb;45(2):172-4. Unique Identifier : AIDSLINE MED/86136628
Ball GD
[Retroviruses, AIDS and systemic lupus erythematosus (editorial)]
Harefuah. 1985 Nov;109(9):251-3. Unique Identifier : AIDSLINE MED/86137844
Schattner A
Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain.
Hum Pathol. 1986 Mar;17(3):271-84. Unique Identifier : AIDSLINE MED/86138293
Sharer LR; Epstein LG; Cho ES; Joshi VV; Meyenhofer MF; Rankin LF; Petito CK
The neuropathologic findings in 11 children with a new CNS disorder that occurs in children with the acquired immunodeficiency syndrome (AIDS) and is postulated to be due to LAV/HTLV-III, the virus that causes AIDS, are reported. The children, who ranged in age from 4 months to 11 years, died of AIDS complicated by pr


Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
Genitourin Med. 1986 Feb;62(1):38-43. Unique Identifier : AIDSLINE MED/86138312
Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
To establish when lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) was introduced into the Netherlands , we studied a cohort of homosexual men who participated in a hepatitis B vaccine efficacy study between 1980 and 1982. On entry into the study (N


Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary.
Immunol Lett. 1985;11(5-6):305-10. Unique Identifier : AIDSLINE MED/86138451
Hollan SR; Fust G; Nagy K; Horvath A; Krall G; Verebelyi K; Ujhelyi E; Varga L; Mayer V
Hungary can be considered as a low risk area for AIDS since no patient with full-blown AIDS or AIDS-related complex has been found in the country. A complex clinical and immunological (T cell subsets, DNCB sensitization test, circul


Clinical analysis of 33 patients with adult T-cell leukemia (ATL)-diagnostic criteria and significance of high- and low-risk ATL.
Int J Cancer. 1986 Mar 15;37(3):335-41. Unique Identifier : AIDSLINE MED/86138741
Tamura K; Nagamine N; Araki Y; Seita M; Okayama A; Kawano K; Tachibana N; Tsuda K; Kuroki Y; Narita H; et al
The clinical characteristics of 33 patients with adult T-cell leukemia (ATL) are described. All patients were born and have lived in Miyazaki Prefecture (southwest of Japan ). Because of a wide range of clinical presentations and courses, they were subdivided into 2 groups. In the hi


Transmission of human T-cell leukemia virus (HTLV-I) by blood transfusion: demonstration of proviral DNA in recipients' blood lymphocytes.
Int J Cancer. 1986 Mar 15;37(3):395-400. Unique Identifier : AIDSLINE MED/86138749
Sato H; Okochi K
Human T-cell clones bearing antigens encoded by human T-cell leukemia/lymphoma virus (HTLV-I) were isolated from 6 patients who produced antibodies against HTLV-I after having received anti-HTLV-I-positive blood units containing cell components. On the other hand, it was not possible to isolate clonal cells carrying v


Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
Int J Cancer. 1986 Mar 15;37(3):451-7. Unique Identifier : AIDSLINE MED/86138756
Balzarini J; Mitsuya H; De Clercq E; Broder S
Suramin and various other selected compounds were evaluated for their in vitro inhibitory effects on the infectivity and replication of human T-cell lymphotropic virus (HTLV/III)/lymphadenopathy-associated virus (LAV). As parameters for infectivity and replication, respectively, we followed the cytopathic effect of HT


[Retroviruses in dermatology]
Hautarzt. 1986 Jan;37(1):6-11. Unique Identifier : AIDSLINE MED/86139149
von der Helm D
Retroviruses have a genomic RNA and can induce malignant tumors. Study of the retroviruses led to the discovery of retroviral oncogenes, which were found to be responsible for the development of malignancies. Later on, cellular genes were detected that are closely related to the viral oncogenes but not oncogenic per s


The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription.
Jpn J Cancer Res. 1985 Dec;76(12):1127-31. Unique Identifier : AIDSLINE MED/86139489
Seiki M; Inoue J; Takeda T; Hikikoshi A; Sato M; Yoshida M
Human T-cell leukemia virus type I has a unique sequence pX and the product p40x was proposed to be a specific trans-acting transcriptional activator of expression of the viral gene. Recently, a second pX protein p27x-III in addition to p40x was identified; these two proteins are encoded by overlapping frames III and


Myristylation of gag protein in human T-cell leukemia virus type-I and type-II.
Jpn J Cancer Res. 1985 Dec;76(12):1132-5. Unique Identifier : AIDSLINE MED/86139490
Ootsuyama Y; Shimotohno K; Miwa M; Oroszlan S; Sugimura T
We found that p19gag of HTLV-I and p23gag of HTLV-II are myristylated. The p28, which is immunologically cross-reactive with monoclonal antibody against p19gag of HTLV-I was also shown to be myristylated in the HTLV-I-infected cell lines MT-2 and HUT102. However, no myristylated p28 was found in HTLV-II-infected cell


Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers.
Jpn J Cancer Res. 1985 Dec;76(12):1147-53. Unique Identifier : AIDSLINE MED/86139493
Kinoshita K; Yamanouchi K; Ikeda S; Momita S; Amagasaki T; Soda H; Ichimaru M; Moriuchi R; Katamine S; Miyamoto T; et al
To obtain definitive evidence that milk-borne infection plays a critical role in the endemy or mother-to-child transmission of human T-cell leukemia virus type-I (HTLV-I), we inoculated concentrated fresh human milk cells obtained from HTLV-I carrier mothers into the oral cavity of a common marmoset (Callithrix jacchu


Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.
J Clin Pharmacol. 1986 Jan;26(1):22-6. Unique Identifier : AIDSLINE MED/86140884
Collins JM; Klecker RW Jr; Yarchoan R; Lane HC; Fauci AS; Redfield RR; Broder S; Myers CE
Suramin has been reported to inhibit the reverse transcriptase activity of a number of retroviruses and to reduce the in vitro infectivity and cytopathic effect of HTLV-III/LAV, the etiologic agent of acquired immune deficiency syndrome (AIDS). The clinical pharmacokinetics of suramin were investigated as part of a pi


Acquired immunodeficiency syndrome manifested as disseminated cryptococcosis.
J Emerg Med. 1985;3(4):275-9. Unique Identifier : AIDSLINE MED/86141560
Pittard G; Seger D
A 32-year-old male homosexual presented to the emergency department (ED) with the clinical picture of a nonspecific illness. While in the ED, he experienced a first-time seizure. Computed tomography (CT) showed an enhancing mass lesion. Antibacterial therapy was started and continued until a second lumbar puncture (LP


C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
J Immunol. 1986 Apr 1;136(7):2393-7. Unique Identifier : AIDSLINE MED/86141838
Palker TJ; Scearce RM; Copeland TD; Oroszlan S; Haynes BF
To study the human host response to viral structural proteins during HTLV type I infection, five synthetic peptides matching the N-terminal and C-terminal regions of HTLVI p19 core protein were used to identify antigenic sites on p19 that were immunogenic in man. In radioimmunoassay and immunoprecipitation experiments


A radioimmunoassay that sandwiches human interleukin-2 between radiolabeled monoclonal antibody and the receptor on a hematopoietic cell line.
J Immunol Methods. 1986 Mar 13;87(2):245-9. Unique Identifier : AIDSLINE MED/86141923
Ohike Y; Imai M; Tanaka E; Mukaida N; Kasahara T; Tachibana K; Miyakawa Y; Mayumi M
Two monoclonal antibodies were raised against human interleukin-2 ( IL-2 ) produced by E. coli harboring recombinant complemental DNA. Both antibodies did not neutralize its activity, nor did they inhibit the binding of IL-2 to the receptor on target cells. Taking advant


The pathogenesis of slow virus infections: molecular analyses.
J Infect Dis. 1986 Mar;153(3):441-7. Unique Identifier : AIDSLINE MED/86141973
Haase AT
Slow infections raise some novel issues in understanding the pathogenesis of viral diseases that have been increasingly addressed at the molecular level with in situ hybridization. These developments are reviewed as the framework for discussion of the realized and potential impact of these investigations for major neu


Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system.
J Infect Dis. 1986 Mar;153(3):601-4. Unique Identifier : AIDSLINE MED/86141992
Katz BZ; Andiman WA; Eastman R; Martin K; Miller G
Effect of intravenous recombinant gamma-interferon on the respiratory burst of blood monocytes from patients with AIDS.
J Infect Dis. 1986 Mar;153(3):609-12. Unique Identifier : AIDSLINE MED/86141994
Pennington JE; Groopman JE; Small GJ; Laubenstein L; Finberg R
Serological characterization of HTLV-III infection in AIDS and related disorders.
J Infect Dis. 1986 Apr;153(4):736-42. Unique Identifier : AIDSLINE MED/86142019
Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S; et al
Current efforts to test blood donors and other persons for exposure to the human T cell lymphotropic virus type III (HTLV-III), the etiologic agent of the acquired immunodeficiency syndrome (AIDS), are based on the measurement of serum antibodies to viral antigens. We studied presence of serum antibodies to HTLV-III-r


Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.
J Infect Dis. 1986 Apr;153(4):788-90. Unique Identifier : AIDSLINE MED/86142026
Kitchen L; Malone G; Orgad S; Barin F; Zaizov R; Ramot B; Gazit E; Kreiss J; Leal M; Wichmann I; et al
High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells.
J Exp Med. 1986 Mar 1;163(3):550-62. Unique Identifier : AIDSLINE MED/86142504
Fujii M; Sugamura K; Sano K; Nakai M; Sugita K; Hinuma Y
Receptor-mediated internalization and degradation of IL-2 were investigated in cell lines carrying human T cell leukemia/lymphoma (lymphotrophic) virus type I (HTLV-I) and PHA-treated normal PBL. The HTLV-I-carrying cell lines ILT-Yan and TL-Mor, and the PBL expressed


Prevalence of anti-oncogenic virus antibodies in patients with malignancies, hemophilia and systemic lupus erythematosus.
Taiwan I Hsueh Hui Tsa Chih. 1985 Sep;84(9):1025-32. Unique Identifier : AIDSLINE MED/86142584
Lin KT; Liu MF; Hsieh RP; Lynn TC; Shen MC; Wang JH; Chen YC; Lai MY; Chen DS; Liu CH; et al
Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient.
J Neuropathol Exp Neurol. 1986 Mar;45(2):127-39. Unique Identifier : AIDSLINE MED/86142838
Wiley CA; Schrier RD; Denaro FJ; Nelson JA; Lampert PW; Oldstone MB
Approximately one-half of autopsied acquired immune deficiency syndrome (AIDS) patients demonstrate probable human cytomegalovirus ( CMV ) infection of the central nervous system (CNS). Because CMV in brain tissue or cerebrospi


Hepatitis B immune globulin as treatment of CMV infections in patients with AIDS.
J Natl Med Assoc. 1986 Jan;78(1):61-2. Unique Identifier : AIDSLINE MED/86143868
Jordan WC
AIDS: no time for apathy.
J Natl Med Assoc. 1986 Feb;78(2):97-8. Unique Identifier : AIDSLINE MED/86143884
Greaves W
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4.
J Virol. 1986 Mar;57(3):1159-62. Unique Identifier : AIDSLINE MED/86144032
Kikukawa R; Koyanagi Y; Harada S; Kobayashi N; Hatanaka M; Yamamoto N
Cells of human leukemic T-cell line Molt-4 which were cloned in soft agarose from individual colonies were analyzed for the cytopathic effect and viral antigen expression after human T-cell lymphotropic virus type III infection. The induction of cytopathic effect and viral antigens by the infection varied significantl


Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.
J Virol. 1986 Mar;57(3):738-44. Unique Identifier : AIDSLINE MED/86144047
Rosen CA; Sodroski JG; Kettman R; Haseltine WA
The ability of the sequences present in the long terminal repeats (LTRs) of human T-cell leukemia viruses type I and II (HTLV-I and HTLV-II) and of bovine leukemia virus to function as enhancer elements was investigated. Recombinant plasmids that contained the HTLV-I, HTLV-II, and bovine leukemia virus LTRs at a dista


Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.
J Virol. 1986 Apr;58(1):116-24. Unique Identifier : AIDSLINE MED/86144082
Fultz PN; McClure HM; Swenson RB; McGrath CR; Brodie A; Getchell JP; Jensen FC; Anderson DC; Broderson JR; Francis DP
The lymphadenopathy-associated virus (LAV) prototype strain of human T-lymphotropic virus type III/LAV was transmitted to juvenile chimpanzees with no prior immunostimulation by (i) intravenous injection of autologous cells infected in vitro, (ii) intravenous injection of cell-free virus, and (iii) transfusion from a


Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.
J Virol. 1986 Apr;58(1):9-16. Unique Identifier : AIDSLINE MED/86144112
Steimer KS; Higgins KW; Powers MA; Stephans JC; Gyenes A; George-Nascimento C; Luciw PA; Barr PJ; Hallewell RA; Sanchez-Pescador R
Sera from the majority of individuals that were positive in an enzyme-linked immunosorbent assay (ELISA) retrovirus (ARV), an isolate of the for antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV), an isolate of the retrovirus identified as the etiologic agent of AIDS, were found to re


HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs [letter]
JAMA. 1986 Apr 4;255(13):1702. Unique Identifier : AIDSLINE MED/86144224
McFadden T; Jason JM; Feorino P
The prevalence of HTLV-III/LAV antibodies in heterosexuals [letter]
JAMA. 1986 Apr 4;255(13):1702-3. Unique Identifier : AIDSLINE MED/86144225
Whittington WL; Kraus SJ; Lee F; Nahmias AJ
Minimal risk of transmission of AIDS-associated retrovirus infection by oral-genital contact [letter]
JAMA. 1986 Apr 4;255(13):1703. Unique Identifier : AIDSLINE MED/86144226
Lyman D; Winkelstein W; Ascher M; Levy JA
Female-to-male transmission of HTLV-III [letter]
JAMA. 1986 Apr 4;255(13):1703-6. Unique Identifier : AIDSLINE MED/86144227
Condoms prevent transmission of AIDS-associated retrovirus [letter]
JAMA. 1986 Apr 4;255(13):1706. Unique Identifier : AIDSLINE MED/86144228
Conant M; Hardy D; Sernatinger J; Spicer D; Levy JA
Preventing the spread of AIDS [letter]
JAMA. 1986 Apr 4;255(13):1706-7. Unique Identifier : AIDSLINE MED/86144229
Wykoff RF
Leads from the MMWR. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
JAMA. 1986 Apr 11;255(14):1843-4, 1849. Unique Identifier : AIDSLINE MED/86144248
Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments.
JAMA. 1986 Apr 11;255(14):1887-91. Unique Identifier : AIDSLINE MED/86144263
Resnick L; Veren K; Salahuddin SZ; Tondreau S; Markham PD
The stability of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) under environmental conditions encountered in a clinical or laboratory setting and its inactivation by commonly used chemical disinfectants were investigated. Under our experimental conditions utilizing a highly c


[Acquired immune deficiency syndrome]
Rinsho Byori. 1985 Nov;33(11):1230-41. Unique Identifier : AIDSLINE MED/86144475
Ikegami N
[Diagnosis of leukemia by genetic engineering]
Rinsho Byori. 1985 Nov;33 Spec No 65:101-6. Unique Identifier : AIDSLINE MED/86144486
Hirai H
[Leukemogenic viruses]
Rinsho Byori. 1985 Nov;33 Spec No 65:96-100. Unique Identifier : AIDSLINE MED/86144504
Hatanaka M
[Attempts at the development of vaccines against adult T-cell leukemia]
Kango Gijutsu. 1985 Dec;31(16):2214-5. Unique Identifier : AIDSLINE MED/86144688
Hayami M
HTLV III antibodies and immunological alterations in hemophilia patients.
Klin Wochenschr. 1986 Feb 3;64(3):115-24. Unique Identifier : AIDSLINE MED/86145216
Seifried E; Pindur G; Stotter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
The clinical, immunological, and serological status of 28 patients with hemophilia A and of 13 patients with hemophilia B was investigated. Thirty-four patients were treated regularly by clotting factor concentrates and 7 patients had been substituted only 1 to 4 times. Almost all patients with severe hemophilia suffe


Acquired immunodeficiency syndrome. A contemporary overview.
Minn Med. 1986 Jan;69(1):29-30. Unique Identifier : AIDSLINE MED/86146429
Crossley K
Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
MMWR Morb Mortal Wkly Rep. 1986 Mar 14;35(10):152-5. Unique Identifier : AIDSLINE MED/86146458
Acquired immunodeficiency syndrome in correctional facilities: a report of the National Institute of Justice and the American Correctional Association.
MMWR Morb Mortal Wkly Rep. 1986 Mar 28;35(12):195-9. Unique Identifier : AIDSLINE MED/86146468
The AIDS epidemic: multidisciplinary trouble.
N Engl J Med. 1986 Mar 20;314(12):779-82. Unique Identifier : AIDSLINE MED/86146778
Osborn JE
Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies. Collaborative DHPG Treatment Study Group.
N Engl J Med. 1986 Mar 27;314(13):801-5. Unique Identifier : AIDSLINE MED/86146785
The drug 9-(1,3-dihydroxy-2-propoxymethyl)-guanine (DHPG) was used to treat serious cytomegalovirus infections in 26 patients with underlying immunodeficiency (including 22 with the acquired immunodeficiency syndrome). In 17 of 22 patients in whom cytomegalovirus was virologically


Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
N Engl J Med. 1986 Apr 3;314(14):874-9. Unique Identifier : AIDSLINE MED/86146806
Birx DL; Redfield RR; Tosato G
Patients with the acquired immunodeficiency syndrome (AIDS) acquire undifferentiated B-cell lymphomas that are similar to African Burkitt s lymphoma and contain Epstein-Barr virus (EBV). Using an in vitro assay system that measures a complex of cellular responses to EBV-infected lymphocytes, we found that B cells from


AIDS [letter]
Nature. 1986 Feb 27-Mar 5;319(6056):716. Unique Identifier : AIDSLINE MED/86146847
AIDS virus and HTLV-I differ in codon choices [letter]
Nature. 1986 Feb 27-Mar 5;319(6056):727-8. Unique Identifier : AIDSLINE MED/86146851
Grantham P; Perrin P
Origin of the human AIDS virus [letter]
Nature. 1986 Feb 27-Mar 5;319(6056):728. Unique Identifier : AIDSLINE MED/86146852
Desrosiers RC
Lack of antibodies to adult T-cell leukaemia virus and to AIDS virus in Israeli Falashas [letter]
Nature. 1986 Feb 27-Mar 5;319(6056):794. Unique Identifier : AIDSLINE MED/86146863
Karpas A; Maayan S; Raz R
Lack of HTLV-I antibodies in Africans [letter]
Nature. 1986 Feb 27-Mar 5;319(6056):794-5. Unique Identifier : AIDSLINE MED/86146864
Weiss RA; Cheingsong-Popov R; Clayden S; Pegram S; Tedder RS; Barzilai A; Rubenstein E
Swiss prize shared [news]
Nature. 1986 Mar 13-19;320(6058):100. Unique Identifier : AIDSLINE MED/86146884
Newmark P
AIDS therapy by blocking CD4 + cells [letter]
Nature. 1986 Mar 13-19;320(6058):113. Unique Identifier : AIDSLINE MED/86146887
Singer A; Shearer GM
AIDS. Pasteur plans to pursue patent suit on virus [news]
Nature. 1986 Mar 13-19;320(6058):96. Unique Identifier : AIDSLINE MED/86146906
Walgate R; Beardsley T
[Role of surgery in the prognosis of AIDS and related syndromes. Case reports ]
Minerva Med. 1986 Mar 10;77(9-10):273-7. Unique Identifier : AIDSLINE MED/86147441
Badellino F; Moresco L; Battistini G; Gipponi M; Percivale P; Dodi F; Anselmo M
The authors review the epidemiologic and etiopathogenetic aspects of AIDS, in agreement with data published in december by the Center for Disease Control and by the WHO for the States, Europe and Italy . In their experience twenty-one patients, with clinical clues of AIDS, undergoing


AIDS update: HTLV-III/LAV infection.
Pa Med. 1986 Jan;89(1):24-6. Unique Identifier : AIDSLINE MED/86148048
Cassens BJ
[Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies]
Pathol Biol (Paris). 1985 Dec;33(10):951-6. Unique Identifier : AIDSLINE MED/86148117
Aymard JP; Janot C; Briquel ME; Andre E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
Blood T-lymphocyte subsets and serum immunoglobulin levels were studied in a group of 52 haemophiliacs (44 patients with haemophilia A and 8 patients with haemophilia B). None of the patients had AIDS or belonged to any AIDS high-risk group. Patients were exclusively treated with clotting fractions obtained from healt


[Autopsy findings in acquired immunodeficiency syndrome (AIDS)]
Pathologe. 1986 Jan;7(1):8-21. Unique Identifier : AIDSLINE MED/86149131
Schmidts HL; Muller H; Falk S; Schneider M; Sakuma T; Hubner K; Stutte HJ
[Identification of C or D virus-type particles in the germinal centers of lymph nodes sampled at the lymphadenopathy stage of the acquired immunodeficiency syndrome (letter)]
Presse Med. 1986 Jan 25;15(3):121. Unique Identifier : AIDSLINE MED/86149141
Le Tourneau A; Audouin J; Tricottet V; Reynes M; Aubert JP; Diebold J
Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.
Proc Natl Acad Sci U S A. 1986 Feb;83(4):1089-91. Unique Identifier : AIDSLINE MED/86149220
Cowan MJ; Brady RO; Widder KJ
Acquired immunodeficiency syndrome (AIDS) is an often fatal disease caused by a retrovirus frequently resulting in malignancy and/or opportunistic infection. Because the immune deficiency in AIDS is similar to that in some purine enzyme deficiencies, we measured erythrocyte adenosine deaminase (ADA) and purine nucleos


Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
Proc Natl Acad Sci U S A. 1986 Mar;83(6):1911-5. Unique Identifier : AIDSLINE MED/86149407
Mitsuya H; Broder S
Human T-lymphotropic virus type III (HTLV-III)/lymphadenopathy-associated virus (LAV) is a a newly discovered lymphotropic retrovirus that is cytopathic for helper/inducer T cells in vitro. This virus is the etiologic agent of the acquired immunodeficiency syndrome and related diseases. In the current study, we tested


[38 year-old male with bilateral pulmonary infiltrates and the septic picture of fatal development (clinical conference)]
Rev Clin Esp. 1985 Dec;177(9):459-67. Unique Identifier : AIDSLINE MED/86150649
[Cerebral toxoplasmosis in AIDS]
ROFO Fortschr Geb Rontgenstr Nuklearmed. 1986 Feb;144(2):230-1. Unique Identifier : AIDSLINE MED/86150675
Christ F; Steudel H; Klotz D
Opportunistic infections in patients with AIDS: clues to the epidemiology of AIDS and the relative virulence of pathogens.
Rev Infect Dis. 1986 Jan-Feb;8(1):21-30. Unique Identifier : AIDSLINE MED/86151077
Blaser MJ; Cohn DL
The frequency of nine reactivating or opportunistic infections and Kaposi s sarcoma among patients with the acquired immunodeficiency syndrome (AIDS) was reviewed. The diagnoses of 87 patients reported from the Colorado AIDS registry and 359 others from literature reports were abstracted, and data were placed in one o


Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Science. 1986 Mar 21;231(4744):1437-40. Unique Identifier : AIDSLINE MED/86151654
Derse D; Casey JW
The bovine leukemia virus, like the human T-cell leukemia viruses (HTLV-I and HTLV-II), are unusual biologically in that viral transcripts are not detected in tumors or infected tissues. The bovine leukemia virus long terminal repeat (BLV LTR) functions as a transcriptional promoter only in cell lines productively inf


AIDS drug shows promise in preliminary clinical trial [news]
Science. 1986 Mar 28;231(4745):1504-5. Unique Identifier : AIDSLINE MED/86151657
Marx JL
A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.
Science. 1986 Mar 28;231(4745):1546-9. Unique Identifier : AIDSLINE GENBANK/K03455
Lee TH; Coligan JE; Allan JS; McLane MF; Groopman JE; Essex M
The DNA of the HTLV-III/LAV group of retroviruses contains certain additional open reading frames that are not found in typical avian or mammalian retroviruses. The role of these sequences in encoding for gene products that may be related to pathogenesis remains to be resolved. An open reading frame whose 5 end overl


Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.
Science. 1986 Mar 28;231(4745):1549-53. Unique Identifier : AIDSLINE GENBANK/K03455
Sodroski J; Goh WC; Rosen C; Tartar A; Portetelle D; Burny A; Haseltine W
The genome of the human T-lymphotropic virus type III (HTLV-III/LAV) has the potential to encode at least three polypeptides in addition to those encoded by the gag, pol, and env genes. In this study, the product of the sor (short open reading frame) region, which overlaps the 3 end of the pol gene, was found to be a


Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.
Science. 1986 Mar 28;231(4745):1553-5. Unique Identifier : AIDSLINE GENBANK/K03455
Kan NC; Franchini G; Wong-Staal F; DuBois GC; Robey WG; Lautenberger JA; Papas TS
The nucleotide sequence of the genome of HTLV-III, the infectious agent etiologically associated with the acquired immune deficiency syndrome, predicts a small open reading frame, termed sor, located between the pol and env genes. A DNA segment containing 82 percent of the sor region was inserted into a prokaryotic ex


Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.
Science. 1986 Mar 28;231(4745):1556-9. Unique Identifier : AIDSLINE MED/86151664
Kennedy RC; Henkel RD; Pauletti D; Allan JS; Lee TH; Essex M; Dreesman GR
In a study performed to determine which regions of the human T-cell lymphotrophic virus type III (HTLV-III) may represent vaccine candidates to prevent the acquired immune deficiency syndrome (AIDS), a synthetic peptide corresponding to amino acid sequence 735 to 752 of the precursor envelope glycoprotein of HTLV-III


Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus.
Science. 1986 Mar 28;231(4745):1567-72. Unique Identifier : AIDSLINE GENBANK/M11841
Power MD; Marx PA; Bryant ML; Gardner MB; Barr PJ; Luciw PA
Simian acquired immune deficiency syndrome (SAIDS) in the macaque genus of monkeys at the California Primate Research Center is apparently caused by infection by a type D retrovirus. The complete nucleotide sequence (8173 base pairs) of a molecular clone of the prototype SAIDS virus isolate, SRV-1, reveals a typical r


HTLV-III gag protein is processed in yeast cells by the virus pol-protease.
Science. 1986 Mar 28;231(4745):1580-4. Unique Identifier : AIDSLINE GENBANK/K03455
Kramer RA; Schaber MD; Skalka AM; Ganguly K; Wong-Staal F; Reddy EP
The gag-pol gene of HTLV-III (human T-lymphotropic virus), the virus linked to AIDS (acquired immune deficiency syndrome), was expressed in yeast, and processing of the gag precursor into proteins of the same size as those in the virion was observed. Processing of the gag gene in yeast cells mimics the process that na


New relatives of AIDS virus found [news]
Science. 1986 Apr 11;232(4747):157. Unique Identifier : AIDSLINE MED/86151696
Marx JL
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
Science. 1986 Apr 11;232(4747):238-43. Unique Identifier : AIDSLINE MED/86151706
Kanki PJ; Barin F; M'Boup S; Allan JS; Romet-Lemonne JL; Marlink R; McLane MF; Lee TH; Arbeille B; Denis F; et al
This report describes serologic evidence for a virus similar to that known as simian T-lymphotropic virus type III of African Green monkeys (STLV-IIIAGM) infecting apparently healthy people in Senegal , West Africa, and the isolation of virus from these individuals. Serum samples f


Social networks and the spread of infectious diseases: the AIDS example.
Soc Sci Med. 1985;21(11):1203-16. Unique Identifier : AIDSLINE MED/86151797
Klovdahl AS
Conceptualizing a population as a set of individuals linked together to form a large social network provides a fruitful perspective for better understanding the spread of some infectious diseases. Data related to AIDS (the acquired immune deficiency syndrome) were used to illustrate the potential usefulness of a netwo


Herpes without vesicles: limited, recurrent genital lesions in an immunodebilitated host.
South Med J. 1986 Mar;79(3):368-70. Unique Identifier : AIDSLINE MED/86151895
Schneiderman H; Robert NJ; Walker S; Memoli VA
We have reported a case of herpes genitalis in a man with acquired immunodeficiency syndrome (AIDS), who was receiving chemotherapy for Hodgkin s disease. The herpes infection was recurrent but limited, without vesicles or the progressive lesions usually seen in AIDS. Studies excluded known causes, and the unusual cha


[AIDS--this century's catastrophe? 1. Origin and cause]
Sykepleien. 1986 Mar 7;73(5):12-7, 26. Unique Identifier : AIDSLINE MED/86152350
Ostby BA
[Current status of AIDS]
Tandlakartidningen. 1985 Jun 1;77(11):603-6. Unique Identifier : AIDSLINE MED/86152412
Sonnerborg A; Julander I; Teivens A
[Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives]
Tidsskr Nor Laegeforen. 1986 Jan 10;106(1):19-21. Unique Identifier : AIDSLINE MED/86152510
Evensen SA; Froland SS; Glomstein A
Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotrophic III virus, type III.
Transfusion. 1986 Mar-Apr;26(2):205-7. Unique Identifier : AIDSLINE MED/86152917
Kuritsky JN; Rastogi SC; Faich GA; Schorr JB; Menitove JE; Reilly RW; Bove JR
From April 22 to July 28, and from October 7 to November 3, 1985 the American Red Cross, the Council of Community Blood Centers, the American Association of Blood Banks, and the American Blood Resources Association provided the Food and Drug Administration with data at 2-week intervals on human T-lymphotropic virus ty


Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western blotting.
Transfusion. 1986 Mar-Apr;26(2):208-9. Unique Identifier : AIDSLINE MED/86152918
Fang CT; Darr F; Kleinman S; Wehling RH; Dodd RY
A population of 73 donor samples was assembled on the basis of reactive results in routine screening with three different licensed human T-lymphotrophic virus type III (HTLV-III) antibody enzyme-linked immunosorbent assay (ELISA) procedures. The samples were retested by a number of licensed and developmental tests and


Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma.
Transfusion. 1986 Mar-Apr;26(2):210-3. Unique Identifier : AIDSLINE MED/86152919
Wells MA; Wittek AE; Epstein JS; Marcus-Sekura C; Daniel S; Tankersley DL; Preston MS; Quinnan GV Jr
Because of concern about the safety of immune globulins prepared for injection, we studied the effects of ethanol fractionation of human plasma on human lymphotropic virus, type III, (HTLV-III) by spiking the products of various fractionation steps with HTLV-III. Tests of inactivation and removal indicated that the ra


A feline retrovirus induced T-lymphoblastoid cell-line that produces an atypical alpha type of interferon.
Vet Immunol Immunopathol. 1986 Jan;11(1):1-19. Unique Identifier : AIDSLINE MED/86153573
Yamamoto JK; Ho E; Pedersen NC
A cell-line, designated LSA-1, was derived from a thymic lymphosarcoma that occurred in a cat with experimentally induced feline leukemia virus (FeLV) infection. LSA-1 cells possessed surface receptors and antigens of normal T-lymphocytes, but were unresponsive to interleukin-2 stimulation. The LSA cell-line was found


Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area.
Virology. 1986 Apr 15;150(1):1-9. Unique Identifier : AIDSLINE MED/86153597
Rasheed S; Norman GL; Gill PS; Meyer PR; Cheng L; Levine AM
Human retroviruses have been causally associated with the development of the acquired immune deficiency syndrome (AIDS) in groups of individuals at high risk including intravenous drug users, hemophiliacs, and homosexual men. Aside from classic AIDS, homosexual men also develop persistent generalized lymphadenopathy (


Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein.
Virology. 1986 Apr 15;150(1):106-16. Unique Identifier : AIDSLINE MED/86153599
Newman MJ; Baker IT; Reitz MS; Eiden M; Blattner WA; Gallo RC; Mann DL
Murine monoclonal antibodies were developed against the protein products produced by murine C127 cells which had been transfected with a recombinant plasmid clone containing the human T-cell leukemia (lymphotropic) virus type I (HTLV-I) proviral DNA coding regions for part of env, px, and the 3 LTR. Four antibodies w


Distribution of type D retrovirus sequences in tissues of macaques with simian acquired immune deficiency and retroperitoneal fibromatosis.
Virology. 1986 Apr 15;150(1):149-60. Unique Identifier : AIDSLINE MED/86153603
Bryant ML; Marx PA; Shiigi SM; Wilson BJ; McNulty WP; Gardner MB
Horizontally acquired SAIDS retrovirus type 2 (SRV-2), a type D retrovirus related to the Mason- Pfizer monkey virus, has been associated with the simian acquired immunodeficiency syndrome (SAIDS) including retroperitoneal fibromatosis (RF) in several macaque species at two


Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria.
Virology. 1986 Apr 15;150(1):283-90. Unique Identifier : AIDSLINE MED/86153618
Steimer KS; Puma JP; Power MD; Powers MA; George-Nascimento C; Stephans JC; Levy JA; Sanchez-Pescador R; Luciw PA; Barr PJ; et al
Infection with the retrovirus that is the etiological agent of acquired immune deficiency syndrome (AIDS) is characterized by the development of antiviral antibodies. To generate reagents for studying immune responses to individual viral proteins, we have produced viral antigens in microorganisms by recombinant DNA te


Transmission of lymphotropic retroviruses (HTLV-I and LAV/HTLV-III) by blood transfusion and blood products.
Vox Sang. 1986;50(1):1-11. Unique Identifier : AIDSLINE MED/86153712
Melief CJ; Goudsmit J
Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
Vox Sang. 1986;50(1):12-5. Unique Identifier : AIDSLINE MED/86153713
Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
95 Dutch haemophiliacs were tested for antibodies to membrane antigens on cells infected with human T-cell leukemia virus type I (HTLV-I-MA) by indirect immunofluorescence and to purified HTLV-I by enzyme-linked immunosorbent assay. Antibodies to HTLV-I-MA were present in 8 of 95 (8%) haemophiliacs, but only 3 (3%) ha


[Leukocyte interferon reaction in patients with primary immunodeficiencies]
Vopr Virusol. 1985 Nov-Dec;30(6):714-7. Unique Identifier : AIDSLINE MED/86153826
Babaiants AA; Manakhova LS; Karganova GG; Porkhovatyi SIa; Kondratenko IV
The capacity of leukocytes from children with primary immunodeficiency to produce alpha- and gamma-interferons in vitro was studied. Interferon response of leukocytes in most of the patients examined was found to be practically unchanged. The immunostimulating therapy in some cases exerted a regulating effect on leuko


[Psoriasis in acquired immunodeficiency syndrome--new aspects for an immunopathogenesis of psoriasis]
Z Hautkr. 1985 Dec 15;60(24):1913-4. Unique Identifier : AIDSLINE MED/86154080
Steigleder GK; Rasokat H
[What should the dentist know about AIDS?]
Zahnarztl Prax. 1985 Aug 9;36(8):302-4. Unique Identifier : AIDSLINE MED/86154418
Braun-Falco O; von der Helm D
HL-A and disease.
Adv Nephrol Necker Hosp. 1986;15:329-51. Unique Identifier : AIDSLINE MED/86155128
Hors J; Gony J
Of more than 500 diseases or syndromes studied for HL-A markers, more than 40 are known to be associated with an allele of class I, II, or III. Seven are linked to the HL-A region: six are recessive (idiopathic hemochromatosis, C2, C4A, and C4B deficiencies, congenital and late-onset deficiencies) and one is dominant


Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
Am J Med. 1986 Mar;80(3):345-50. Unique Identifier : AIDSLINE MED/86155811
Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
A cohort of 63 hemophiliac subjects was followed for clinical and immunologic abnormalities related to the acquired immune deficiency syndrome (AIDS). When evaluated in early 1984, antibody to human T cell leukemia virus type III (HTLV-III) was detected in the serum of 59 percent (24 of 41) of factor VIII or IX concen


Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy.
Am J Med. 1986 Mar;80(3):357-63. Unique Identifier : AIDSLINE MED/86155813
Mayer KH; Ayotte D; Groopman JE; Stoddard AM; Sarngadharan M; Gallo R
Forty asymptomatic homosexually active men seen at a Boston community health center and 39 men with generalized lymphadenopathy were interviewed and filled out detailed epidemiologic questionnaires. Twenty percent of the asymptomatic men and 92 percent of those with lymphadenopathy had antibodies to human T lymphotrop


HTLV-III screening by eye banks [letter]
Am J Ophthalmol. 1986 Mar 15;101(3):385-6. Unique Identifier : AIDSLINE MED/86156060
Mannis MJ; Brightbill FS; Moore TJ
Application of a modified computer algorithm in determining potential antigenic determinants associated with the AIDS virus glycoprotein.
Anal Biochem. 1985 Dec;151(2):540-6. Unique Identifier : AIDSLINE MED/86156706
Pauletti D; Simmonds R; Dreesman GR; Kennedy RC
A computer program was developed for use on an Apple IIe that utilized the parameters developed by Hopp and Woods (T. P. Hopp and K. R. Woods, 1983, Mol. Immunol. 20, 483-489) for predicting the hydrophilic regions of a given protein. This program will produce a listing of the hydrophilic sequence averages and graphic


Infection control and the pregnant health care worker.
Am J Infect Control. 1986 Feb;14(1):20-7. Unique Identifier : AIDSLINE MED/86156978
Valenti WM
Health care workers may be exposed to a variety of infectious agents in the workplace. The pregnant health care worker presents additional concerns because of the potential risk of infection to the developing fetus. Health care workers often misunderstand the basic elements of infection transmission. The result of thi


Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies.
Ann Intern Med. 1986 Apr;104(4):476-81. Unique Identifier : AIDSLINE MED/86157210
Emanuel D; Peppard J; Stover D; Gold J; Armstrong D; Hammerling U
Bronchoalveolar lavage material from 54 immunocompromised patients with interstitial pneumonia was examined by immunofluorescence with cytomegalovirus-specific monoclonal antibodies. Twelve patients (22%) had cytomegalovirus detected in their lavaged cells, and 9 of these patients (17%) had proven cytomegalovirus pneu


Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study.
Ann Intern Med. 1986 Apr;104(4):496-500. Unique Identifier : AIDSLINE MED/86157213
Melbye M; Biggar RJ; Ebbesen P; Neuland C; Goedert JJ; Faber V; Lorenzen I; Skinhoj P; Gallo RC; Blattner WA
The long-term effects of seropositivity for human T-lymphotropic virus type III (HTLV-III) on T-lymphocyte subsets and health status were evaluated in longitudinal studies of 250 initially healthy homosexual men. The relative risk of having an inverted T-lymphocyte helper-to-suppressor ratio rose from 14.3-fold among


Acquired immunodeficiency syndrome. Health and Public Policy Committee, American College of Physicians; and The Infectious Diseases Society of America.
Ann Intern Med. 1986 Apr;104(4):575-81. Unique Identifier : AIDSLINE MED/86157229
Breakthrough of cytomegalovirus infection despite 9-(1,3-dihydroxy-2-propoxymethyl)guanine therapy [letter]
Ann Intern Med. 1986 Apr;104(4):587. Unique Identifier : AIDSLINE MED/86157238
Bach MC
Cytomegalovirus infection, ascending myelitis, and pulmonary embolus [letter]
Ann Intern Med. 1986 Apr;104(4):587. Unique Identifier : AIDSLINE MED/86157239
Bagley PH; Scott DA; Smith LS; Schillaci RF
Diagnosis for interstitial lung disease in patients with acquired immunodeficiency syndrome (AIDS): a prospective comparison of bronchial washing, alveolar lavage, transbronchial lung biopsy, and open-lung biopsy.
Ann Thorac Surg. 1986 Mar;41(3):318-21. Unique Identifier : AIDSLINE MED/86157902
McKenna RJ Jr; Campbell A; McMurtrey MJ; Mountain CF
This study was undertaken to compare prospectively the diagnostic yield of the various bronchoscopic techniques with that of open-lung biopsy for interstitial lung disease in patients with acquired immunodeficiency syndrome (AIDS). Under general anesthesia, 15 patients sequentially underwent bronchial washing, transbr


Murine cytomegalovirus adrenalitis in athymic nude mice.
Arch Virol. 1986;88(1-2):27-35. Unique Identifier : AIDSLINE MED/86158336
Shanley JD; Pesanti EL
During studies of the pathogenesis of murine cytomegalovirus (MCMV) infection in athymic nude mice, we noted striking virus involvement of the adrenal glands. Because patients with the acquired immunodeficiency syndrome (AIDS) have recently been reported to have adrenal necrosis an


Type C retroviruses of the human T cell leukemia family are not evident in patients with systemic lupus erythematosus.
Arthritis Rheum. 1986 Feb;29(2):185-8. Unique Identifier : AIDSLINE MED/86158912
Boumpas DT; Popovic M; Mann DL; Balow JE; Tsokos GC
Type C retroviruses of the human T cell leukemia virus (HTLV) family have been implicated in immune aberrations observed in patients with leukemias, lymphomas, and the acquired immune deficiency syndrome. We have investigated whether retroviruses of the HTLV family are involved in the etiopathogenesis of systemic lupu


[Detection of antibody to adult T cell leukemia associated antigen (ATLA) utilizing laser flow cytometry]
Rinsho Ketsueki. 1985 Oct;26(10):1575-9. Unique Identifier : AIDSLINE MED/86144372
Hara A; Yasuda K; Yokoyama M
AIDS: dilemmas for the psychiatrist [letter]
Lancet. 1986 Mar 1;1(8479):496-7. Unique Identifier : AIDSLINE MED/86145806
Pinching AJ
HTLV-III antibodies in patients with kidney transplants or on haemodialysis [letter]
Lancet. 1986 Mar 1;1(8479):497. Unique Identifier : AIDSLINE MED/86145807
Neumayer HH; Wagner K; Kresse S
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS.
Lancet. 1986 Mar 8;1(8480):525-7. Unique Identifier : AIDSLINE MED/86145842
Vogt MW; Witt DJ; Craven DE; Byington R; Crawford DF; Schooley RT; Hirsch MS
Cervical secretions from 14 women seropositive for HTLV-III/LAV were obtained between days 7 and 21 of the menstrual cycle and cultured for virus. HTLV-III/LAV was isolated from cervical secretions in 4 of 14 women, as well as from blood of 7 of 13 women tested. Female genital secretions may therefore be a source for


Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus.
Lancet. 1986 Mar 8;1(8480):527-9. Unique Identifier : AIDSLINE MED/86145843
Wofsy CB; Cohen JB; Hauer LB; Padian NS; Michaelis BA; Evans LA; Levy JA
The AIDS-associated retrovirus (ARV) was isolated from vaginal and/or cervical secretions from 4 out of 8 women whose sera contained antibodies to the virus. The quantity of virus recovered initially was so low that identification of ARV was accomplished only after passage of the isolates to cultured mitogen-stimulate


African swine fever virus and AIDS [letter]
Lancet. 1986 Mar 8;1(8480):564-5. Unique Identifier : AIDSLINE MED/86145879
Beldekas J; Teas J; Hebert JR
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
Lancet. 1986 Mar 15;1(8481):575-80. Unique Identifier : AIDSLINE MED/86145883
Yarchoan R; Klecker RW; Weinhold KJ; Markham PD; Lyerly HK; Durack DT; Gelmann E; Lehrman SN; Blum RM; Barry DW; et al
In a 6-week clinical trial 4 dose regimens of 3 -azido-3 -deoxythymidine ( AZT ), a thymidine analogue with potent anti-viral activity against HTLV-III in vitro, were examined in 19 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-rel


Isolation of retroviruses from two patients with common variable hypogammaglobulinaemia.
Lancet. 1986 Mar 15;1(8481):581-3. Unique Identifier : AIDSLINE MED/86145884
Webster AD; Dalgleish AG; Malkovsky M; Beattie R; Patterson S; Asherson GL; North M; Weiss RA
Retroviruses related to human T-lymphotropic virus III/lymphadenopathy-associated virus (HTLV-III/LAV) have been isolated from peripheral-blood mononuclear cells of two patients with common variable hypogammaglobulinaemia who were being treated with intravenous gammaglobulin. One has had three different opportunistic


HTLV-III seroconversion associated with heat-treated factor VIII concentrate [letter]
Lancet. 1986 Mar 15;1(8481):611-2. Unique Identifier : AIDSLINE MED/86145899
White GC 2d; Matthews TJ; Weinhold KJ; Haynes BF; Cromartie HL; McMillan CW; Bolognesi DP
AIDS: a challenge for the public health.
Lancet. 1986 Mar 22;1(8482):662-6. Unique Identifier : AIDSLINE MED/86145939
Acheson ED
Estimation of risk of outcomes of HTLV-III infection [letter]
Lancet. 1986 Mar 22;1(8482):677-8. Unique Identifier : AIDSLINE MED/86145948
Hunter DJ; De Gruttola V
False-positive HTLV-III antibody tests in multitransfused patients with thalassaemia [letter]
Lancet. 1986 Mar 22;1(8482):678. Unique Identifier : AIDSLINE MED/86145949
Michail-Merianou V; Tzivaras A; Piperi-Lowes L; Kattamis C; Ladis V; Papadakou-Lagogianni R
HTLV-III antibody in a breeding chimpanzee not experimentally exposed to the virus [letter]
Lancet. 1986 Mar 22;1(8482):678-9. Unique Identifier : AIDSLINE MED/86145950
Gilden RV; Arthur LO; Robey WG; Kelliher JC; Graham CE; Fischinger PJ
Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus.
Microbiol Immunol. 1985;29(11):1083-7. Unique Identifier : AIDSLINE MED/86146278
Tsuchie H; Kawatani T; Nakayama E; Matsui T; Kurimura T; Hinuma Y
The level of antibody to AIDS-associated virus (LAV) in sera from patients with AIDS or AIDS related diseases (AIDS related complex; ARC) and Japanese hemophiliacs was studied using indirect immunofluorescence. Titer of anti-LAV antibody in sera from 89 patients with AIDS or ARC ranged between 10 and 40,960 (median: 1



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 1986. AEGiS.